India’s National Pharmaceutical Pricing Authority has moved to cap the selling price of 43 drug formulations. Commonly used antibiotic drugs such as ciprofloxacin, cloxacillin and rifampicin will now be reduced in price by as much as 50 percent. How will this impact pharmaceutical companies? Read more here. (Source: FirstWord Pharma, 9/19/14).
You are here: / / How Will NPPA’s Price Cap Affect Pharma?